Ethics code: IR.IAU.PS.REC.1401.074
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khalili Samani S, Khalifeh S, Vahiddastjerdi M, Hassanzad M, Kheradmand A, Nazari Serenjeh F. The Effect of Memantine on the Expression of Dopamine Receptors in the Striatum of Male Rats With Morphine Addiction. Qom Univ Med Sci J 2023; 17 : 1340.3
URL: http://journal.muq.ac.ir/article-1-3675-en.html
URL: http://journal.muq.ac.ir/article-1-3675-en.html
Sahar Khalili Samani1 
, Solmaz Khalifeh2 , Mehdi Vahiddastjerdi3 , Mandana Hassanzad4 , Afshin Kheradmand5 , Farzaneh Nazari Serenjeh * 6
, Solmaz Khalifeh2 , Mehdi Vahiddastjerdi3 , Mandana Hassanzad4 , Afshin Kheradmand5 , Farzaneh Nazari Serenjeh * 6
1- Department of Genetics, Faculty of Advanced Scinece and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
2- Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
3- Department of Neurology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
4- Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
5- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
6- Department of Biology, Payame Noor University (PNU), Tehran, Iran. ,nazari.f@pnu.ac.ir
2- Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
3- Department of Neurology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
4- Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
5- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
6- Department of Biology, Payame Noor University (PNU), Tehran, Iran. ,
Abstract: (627 Views)
Background and Objectives: Studies have indicated that the chronic use of morphine can result in physical and psychological dependence. Morphine dependence is associated with several cellular and molecular alterations in the mesocorticolimbic system, and striatal dopamine signaling is involved in this process. In the present study, we aim to investigate possible alterations in the level of dopamine receptors DRD2 and DRD4 in the striatum of male rats following chronic oral administration of morphine and assess the effect of subcutaneous injection of memantine on morphine-induced effects.
Methods: In this experimental study, 16 male Wistar rats were randomly divided into four groups: Control, morphine, memantine, and morphine+memantine. The morphine group received increasing doses of morphine (0.1-0.4 mg/kg) via their drinking water for 21 consecutive days. The memantine groups, after receiving distilled water without morphine for 21 days, received a subcutaneous injection of 5 mg memantine. The morphine memantine group received 5 mg of memantine subcutaneously on day 21 and 30 minutes after the last oral administration of morphine. After collecting striatum tissue, dopamine receptor levels were evaluated by the western blotting method.
Results: The chronic use of morphine increased the levels of DRD2 and DRD4 compared to the controls. Memantine administration also increased the level of these receptors compared to the controls. In addition, the expression of DRD2 and DRD4 increased in the morphine+ memantine group compared to the memantine group.
Conclusion: Morphine affects the expression of dopamine receptors in the striatum. Treatment with memantine can increases dopamine receptors’ expression.
Methods: In this experimental study, 16 male Wistar rats were randomly divided into four groups: Control, morphine, memantine, and morphine+memantine. The morphine group received increasing doses of morphine (0.1-0.4 mg/kg) via their drinking water for 21 consecutive days. The memantine groups, after receiving distilled water without morphine for 21 days, received a subcutaneous injection of 5 mg memantine. The morphine memantine group received 5 mg of memantine subcutaneously on day 21 and 30 minutes after the last oral administration of morphine. After collecting striatum tissue, dopamine receptor levels were evaluated by the western blotting method.
Results: The chronic use of morphine increased the levels of DRD2 and DRD4 compared to the controls. Memantine administration also increased the level of these receptors compared to the controls. In addition, the expression of DRD2 and DRD4 increased in the morphine+ memantine group compared to the memantine group.
Conclusion: Morphine affects the expression of dopamine receptors in the striatum. Treatment with memantine can increases dopamine receptors’ expression.
Article number: 1340.3
Type of Study: Original Article |
Subject:
فیزیولوژی
Received: 2023/02/14 | Accepted: 2023/06/21 | Published: 2023/08/1
Received: 2023/02/14 | Accepted: 2023/06/21 | Published: 2023/08/1
References
1. Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci. 2018; 41:453-73. [DOI:10.1146/annurev-neuro-080317-061522] [PMID] [PMCID] [DOI:10.1146/annurev-neuro-080317-061522]
2. Listos J, Łupina M, Talarek S, Mazur A, Orzelska-Górka J, Kotlińska J. The mechanisms involved in morphine addiction: An overview. Int J Mol Sci. 2019; 20(17):4302. [DOI:10.3390/ijms20174302] [PMID] [DOI:10.3390/ijms20174302]
3. Wise RA, Robble MA. Dopamine and addiction. Annu Rev Psychol. 2020; 71:79-106. [DOI:10.1146/annurev-psych-010418-103337] [PMID] [DOI:10.1146/annurev-psych-010418-103337]
4. Rivera A, Suárez-Boomgaard D, Miguelez C, Valderrama-Carvajal A, Baufreton J, Shumilov K, et al. Dopamine D4 receptor is a regulator of morphine-induced plasticity in the rat dorsal striatum. Cells. 2021; 11(1):31. [DOI:10.3390/cells11010031] [PMID] [DOI:10.3390/cells11010031]
5. Trifilieff P, Martinez D. Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology. 2014; 76 Pt B(0):498-509. [DOI:10.1016/j.neuropharm.2013.06.031] [PMID] [DOI:10.1016/j.neuropharm.2013.06.031]
6. Funada M, Shippenberg TS. Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behav Pharmacol. 1996; 7(5):448-53.[PMID]
7. Dai WL, Xiong F, Yan B, Cao ZY, Liu WT, Liu JH, et al. Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord. Sci Rep. 2016; 6:38746. [DOI:10.1038/srep38746] [PMID] [PMCID] [DOI:10.1038/srep38746]
8. Liu J, Nickolenko J, Sharp FR. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A. 1994; 91(18):8537-41. [DOI:10.1073/pnas.91.18.8537] [PMID] [DOI:10.1073/pnas.91.18.8537]
9. Rivera A, Gago B, Suárez-Boomgaard D, Yoshitake T, Roales-Buján R, Valderrama-Carvajal A, et al. Dopamine D4 receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: Relevance for drug addiction. Addict Biol. 2017; 22(5):1232-45. [DOI:10.1111/adb.12407] [PMID] [DOI:10.1111/adb.12407]
10. Georges F, Stinus L, Bloch B, Le Moine C. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci. 1999; 11(2):481-90. [DOI:10.1046/j.1460-9568.1999.00462.x] [PMID] [DOI:10.1046/j.1460-9568.1999.00462.x]
11. Suárez-Boomgaard D, Gago B, Valderrama-Carvajal A, Roales-Buján R, Van Craenenbroeck K, Duchou J, et al. Dopamine D₄ receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen. Int J Mol Sci. 2014; 15(1):1481-98. [DOI:10.3390/ijms15011481] [PMID] [DOI:10.3390/ijms15011481]
12. Elias AM, Pepin MJ, Brown JN. Adjunctive memantine for opioid use disorder treatment: A systematic review. J Subst Abuse Treat. 2019; 107:38-43. [DOI:10.1016/j.jsat.2019.10.003] [PMID] [DOI:10.1016/j.jsat.2019.10.003]
13. Seeman P, Caruso C, Lasaga M. Memantine agonist action at dopamine D2High receptors. Synapse. 2008; 62(2):149-53. [DOI:10.1002/syn.20472] [PMID] [DOI:10.1002/syn.20472]
14. Marvanová M, Lakso M, Pirhonen J, Nawa H, Wong G, Castrén E. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci. 2001; 18(3):247-58. [DOI:10.1006/mcne.2001.1027] [PMID] [DOI:10.1006/mcne.2001.1027]
15. Rostami F, Oryan S, Ahmadiani A, Dargahi L. Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit. J Mol Neurosci. 2012; 48(1):22-34. [DOI:10.1007/s12031-012-9726-4] [PMID] [DOI:10.1007/s12031-012-9726-4]
16. Alderks CE. Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003-2015 (update). Rockville: Ubstance Abuse and Mental Health Services Administration; 2017. [PMID]
17. Ayanga D, Shorter D, Kosten TR. Update on pharmacotherapy for treatment of opioid use disorder. Expert Opin Pharmacother. 2016; 17(17):2307-18. [DOI:10.1080/14656566.2016.1244529] [PMID] [DOI:10.1080/14656566.2016.1244529]
18. Nestler EJ. Molecular mechanisms of drug addiction. Neuropharmacology. 2004;47(Suppl 1):24-32. [DOI:10.1016/j.neuropharm.2004.06.031] [PMID] [DOI:10.1016/j.neuropharm.2004.06.031]
19. Abul-Husn NS, Annangudi SP, Ma'ayan A, Ramos-Ortolaza DL, Stockton SD Jr, Gomes I, et al. Chronic morphine alters the presynaptic protein profile: Identification of novel molecular targets using proteomics and network analysis. Plos One. 2011; 6(10):e25535. [DOI:10.1371/journal.pone.0025535] [PMID] [PMCID] [DOI:10.1371/journal.pone.0025535]
20. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: Results of imaging studies and treatment implications. Arch Neurol. 2007; 64(11):1575-9 [DOI:10.1001/archneur.64.11.1575] [PMID] [DOI:10.1001/archneur.64.11.1575]
21. Yu G, Yan H, Gong ZH. Differential effects of acute and repeated morphine treatment on κ-opioid receptor mRNA levels in mesocorticolimbic system. Pharmacol Rep. 2012; 64(2):445-8. [DOI:10.1016/S1734-1140(12)70786-7] [PMID] [DOI:10.1016/S1734-1140(12)70786-7]
22. Yu G, Yan H, Gong ZH. Effects of acute and repeated morphine treatment on κ-opioid receptor protein levels in mesocorticolimbic system. J Recept Signal Transduct Res. 2014; 34(1):44-7. [DOI:10.3109/10799893.2013.856919] [PMID] [DOI:10.3109/10799893.2013.856919]
23. Nair VD, Savelli JE, Mishra RK. Modulation of dopamine D2 receptor expression by an NMDA receptor antagonist in rat brain. J Mol Neurosci. 1998; 11(2):121-6. [DOI:10.1385/JMN:11:2:121] [PMID] [DOI:10.1385/JMN:11:2:121]
24. Verma A, Kulkarni SK. Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Eur Neuropsychopharmacol. 1995; 5(2):81-7. [DOI:10.1016/0924-977X(94)00140-7] [PMID] [DOI:10.1016/0924-977X(94)00140-7]
25. Semenova S, Danysz W, Bespalov A. Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice. Eur J Pharmacol. 1999; 378(1):1-8. [DOI:10.1016/S0014-2999(99)00431-8] [PMID] [DOI:10.1016/S0014-2999(99)00431-8]
26. Chen Y, Evola M, Young AM. Memantine and dizocilpine interactions with antinociceptive or discriminative stimulus effects of morphine in rats after acute or chronic treatment with morphine. Psychopharmacology. 2013; 225(1):187-99.[DOI:10.1007/s00213-012-2807-9] [PMID] [PMCID] [DOI:10.1007/s00213-012-2807-9]
27. Chen SL, Tao PL, Chu CH, Chen SH, Wu HE, Tseng LF, et al. Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol. 2012; 7(2):444-53. [DOI:10.1007/s11481-011-9337-9] [PMID] [PMCID] [DOI:10.1007/s11481-011-9337-9]
28. Sukhotina IA, Bespalov AY. Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice. Psychopharmacology. 2000; 149(4):345-50. [DOI:10.1007/s002130000386] [PMID] [DOI:10.1007/s002130000386]
29. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015; 156:243-53. [DOI:10.1016/j.drugalcdep.2015.09.020] [PMID] [DOI:10.1016/j.drugalcdep.2015.09.020]
30. Popik P, Skolnick P. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol Biochem Behav. 1996; 53(4):791-7. [DOI:10.1016/0091-3057(95)02163-9] [PMID] [DOI:10.1016/0091-3057(95)02163-9]
31. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodríguez-Arias M, Miñarro J. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28(6):1035-43. [DOI:10.1016/j.pnpbp.2004.05.038] [PMID] [DOI:10.1016/j.pnpbp.2004.05.038]
32. Zhou X, Wang L, Xiao W, Su Z, Zheng C, Zhang Z, et al. Memantine Improves cognitive function and alters hippocampal and cortical proteome in triple transgenic mouse model of Alzheimer's Disease. Exp Neurobiol. 2019; 28(3):390-403. [DOI:10.5607/en.2019.28.3.390] [PMID] [DOI:10.5607/en.2019.28.3.390]
33. Lannes B, Micheletti G, Warter JM, Zwiller J. [Chronic administration of N-methyl-D-aspartate (NMDA) receptor antagonists induced in rats, a facilitation of striatal dopaminergic type D2 transmission: Behavioral and biochemical study (French)]. C R Acad Sci III. 1992; 315(10):387-94. [PMID]
34. Maler JM, Esselmann H, Wiltfang J, Kunz N, Lewczuk P, Reulbach U, et al. Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons. Brain Res. 2005; 1052(2):156-62.[DOI:10.1016/j.brainres.2005.06.017] [PMID] [DOI:10.1016/j.brainres.2005.06.017]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2008-1375
pISSN: 1735-7799
Email: journal[at]muq.ac.ir
j.mua.ac[at]gmail.com
